Characteristics of Patients with Mild to Moderate Primary Pulmonary Coccidioidomycosis

Blair, Janis E.; Chang, Yu-Hui H.; Cheng, Meng-Ru; Vaszar, Laszlo T.; Vikram, Holenarasipur R.; Orenstein, Robert; Kusne, Shimon; Ho, Stanford; Seville, Maria T.; Parish, James M.

doi:10.3201/eid2006.131842

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Characteristics of Patients with Mild to Moderate Primary Pulmonary Coccidioidomycosis

Published Date:

Jun 2014

Publisher's site:

http://dx.doi.org/10.3201/eid2006.131842 New Site Icon

Source:

Emerg Infect Dis. 20(6):983-990.

[PDF-474.35 KB]

Details:

Alternative Title:

Emerg Infect Dis

Personal Author:

Blair, Janis E. ; Chang, Yu-Hui H. ; Cheng, Meng-Ru ; Vaszar, Laszlo T. ; Vikram, Holenarasipur R. ; ... More ▼

Description:

In Arizona, USA, primary pulmonary coccidioidomycosis accounts for 15%-29% of community-acquired pneumonia. To determine the evolution of symptoms and changes in laboratory values for patients with mild to moderate coccidioidomycosis during 2010-2012, we conducted a prospective 24-week study of patients with primary pulmonary coccidioidomycosis. Of the 36 patients, 16 (44%) were men and 33 (92%) were White. Median age was 53 years, and 20 (56%) had received antifungal treatment at baseline. Symptom scores were higher for patients who received treatment than for those who did not. Median times from symptom onset to 50% reduction and to complete resolution for patients in treatment and nontreatment groups were 9.9 and 9.1 weeks, and 18.7 and 17.8 weeks, respectively. Median times to full return to work were 8.4 and 5.7 weeks, respectively. One patient who received treatment experienced disseminated infection. For otherwise healthy adults with acute coccidioidomycosis, convalescence was prolonged, regardless of whether they received antifungal treatment.

Subject:

[+]

Document Type:

Journal Article

Collection(s):

Emerging Infectious Diseases

Main Document Checksum:

[+]

Supporting Files:

	13-1842-F1.gif	image/gif
	13-1842-F1.jpg	image/jpeg
	13-1842-F2.gif	image/gif
	13-1842-F2.jpg	image/jpeg
	13-1842.nxml	text/plain
	license.txt	text/plain

No Related Documents.

You May Also Like:

Cost-effectiveness of a potential vaccine for Coccidioides immitis.

Personal Author:

Barnato, A. E.; Sanders, G. D.; Owens, D. K.;

Published Date:

2001 Sep-Oct

Source:

Emerg Infect Dis. 7(5):797-806.

Description:

Coccidioidomycosis, a systemic fungal infection, affects Americans living in the Southwest. We evaluated the cost- effectiveness of a potential vaccine against Coccidioides immitis. Using a decision model we developed, we estimate that among children...

File Type:

[PDF - 126.98 KB]
Enhanced Surveillance for Coccidioidomycosis, 14 US States, 2016

Personal Author:

Benedict, Kaitlin; Ireland, Malia; Weinberg, Meghan P.; Gruninger, Randon J.; Weigand, Jenna; Chen, Lei; Perez-Lockett, Katharine; Bledsoe, Catherine; Denny, Lynn; Cibulskas, Katie; Gibbons-Burgener, Suzanne; Kocharian, Anna; DeBess, Emilio; Miller, Tracy K.; Lepp, Alicia; Cronquist, Laura; Warren, Kimberly; Serrano, Jose Antonio; Loveland, Cody; Turabelidze, George; McCotter, Orion; Jackson, Brendan R.;

Published Date:

July 2018

Source:

Emerg Infect Dis. 24(8):1444-1452

Description:

Although coccidioidomycosis in Arizona and California has been well-characterized, much remains unknown about its epidemiology in states where it is not highly endemic. We conducted enhanced surveillance in 14 such states in 2016 by identifying cases...

File Type:

[PDF - 1.08 MB]
Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant-Associated Infection Surveillance Network (TRANSNET)

Personal Author:

Kauffman, C.A.; Freifeld, A.G.; Andes, D.R.; Baddley, J.W.; Herwaldt, L.; Walker, R.C.; Alexander, B.D.; Anaissie, E.J.; Benedict, K.; Ito, J.I.; Knapp, K.M.; Lyon, G.M.; Marr, K.A.; Morrison, V.A.; Park, B.J.; Patterson, T.F.; Schuster, M.G.; Chiller, T.M.; Pappas, P.G.;

Published Date:

Mar 04 2014

Source:

Transpl Infect Dis. 16(2):213-224.

Description:

BackgroundInvasive fungal infections are a major cause of morbidity and mortality among solid organ transplant (SOT) and hematopoietic cell transplant (HCT) recipients, but few data have been reported on the epidemiology of endemic fungal infections ...

File Type:

[PDF - 252.44 KB]
Coccidioidomycosis-associated Hospitalizations, California, USA, 2000–2011

Personal Author:

Sondermeyer, Gail; Lee, Lauren; Gilliss, Debra; Tabnak, Farzaneh; Vugia, Duc;

Published Date:

Oct 2013

Source:

Emerg Infect Dis. 19(10):1590-1597.

Description:

In the past decade, state-specific increases in the number of reported cases of coccidioidomycosis have been observed in areas of California and Arizona where the disease is endemic. Although most coccidioidomycosis is asymptomatic or mild, infection...

File Type:

[PDF - 468.68 KB]
Mycotic Infections Acquired outside Areas of Known Endemicity, United States

Personal Author:

Benedict, Kaitlin; Thompson, George R.; Deresinski, Stan; Chiller, Tom;

Published Date:

Nov 2015

Source:

Emerg Infect Dis. 21(11):1935-1941

Description:

In the United States, endemic mycoses--blastomycosis, coccidioidomycosis, and histoplasmosis--pose considerable clinical and public health challenges. Although the causative fungi typically exist within broadly defined geographic areas or ecologic ni...

File Type:

[PDF - 578.92 KB]